Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Clinical evolution

Encorium Group signs $2m in new contracts, results indicate tough market

30-Apr-2009 -  US contract research organisation (CRO) Encorium has reported $2m in new and repeat business deals on the same day it posted gloomy Q4 figures and cited the "drop in demand"...

Covance is latest CRO to cut 2009 forecast on lower Q1 demand

30-Apr-2009 -  New Jersey, US based Covance is the latest CRO to cut earnings projections and blame falling pharmaceutical industry demand for its woes.

Microsoft launches Amalga for R&D and trial data management

29-Apr-2009 -  US software giant Microsoft has unveiled its new Amalga Life Sciences data aggregation and modelling platform in a bid to capitalise on the demand for IT infrastructure solutions currently sweeping...

News in brief

DCS and NextDocs team up on compliance doc management

29-Apr-2009 -  DCS Hosted Solutions and NextDocs are teaming up to provide pharma and biotech firms with a compliance document management system that cuts the time taken to commercilize drugs. 

News in brief

Mene accredited under new Turkish trial regs

28-Apr-2009 -  Turkish CRO Mene Research has become the first trials group to be accredited by the country’s Ministry of Health under new trial laws introduced in January. 

CPI adds TrialMaster EDC tech to offering

27-Apr-2009 - German CRO Clinicalprojects International (CPI) will begin providing its customers with the TrialMaster EDC solution though a deal with developer OmniComm. 

Project cancellations dominate Kendle’s gloomy Q1 forecast

22-Apr-2009 - US firm Kendle is the latest CRO to revise its forecast and blame “unprecedented biopharmaceutical industry conditions,” which are fast becoming an industry catchphrase, for its Q1 woes.

Bio-Path calls in Acorn to help with siRNA drug trial

22-Apr-2009 -  Bio-Path Holdings has called in US CRO Acorn to provide a contract medical officer for a study of its candidate antisense cancer drug liposomal Grb-2. 

PhRMA revises principles to increase transparency

21-Apr-2009 -  Following calls for increased transparency PhRMA has published its new clinical trial principles, which contain revisions relating to registration, authors and sponsor disclosure.

ChemDiv buys Russia’s Prudentas

20-Apr-2009 -  US clinical trials firm ChemDiv has bought Russian CRO Prudentas, boosting its presence in the country at a time when the treatment naïve populations in Eastern Europe are increasingly catching...

Siro ClinPharm and ACT team up on oncology

20-Apr-2009 -  Indian CRO Siro ClinPharm is teaming up with New Jersey based pharma services firm Advanced Clinical Trial Solutions (ACT) to strengthen its position in the US cancer trial sector.

Mandatory registration for Indian clinical trials

17-Apr-2009 -  From June onwards drug firms and CROs conducting trials in India are required to record full details of the research, including the funding source, on the ICMR’s Clinical Trials Registry...

Recruitment a growing problem for trials, says CEI

17-Apr-2009 - Finding appropriate subjects in the booming trials market is a major stumbling block for drug firms and CROs, according to a new study by US market analysts Cutting Edge Information

2008 a growth year says Germany’s XClinical

16-Apr-2009 -  Germany’s XClinical says 2008 was a successful year with a 20 per cent hike in revenues for its electronic data capture (EDC) and clinical data/trial management (CDM/CTM) software. ...

Radiant broadens Indian clinical research Spectrum

14-Apr-2009 -  Cincinnati, US site management organisation (SMO) Radiant Research says that growing industry demand for trials outside the US is the key motivation for the link up with India’s Spectrum Clinical...

News in brief

Some CROs benefiting more than others

14-Apr-2009 -  While CROs are “reaping the benefits” of the pharmaceutical industry’s efforts to save money, certain types of clinical research are being farmed out more often than others, according to a...

CROs pursue international expansion

09-Apr-2009 -  The past few days have seen a string of announcements from contract research organisations (CROs) which indicate that their appetite for international expansion and development remains unsated. 

CardioNet breaks into CRO sector with Biotel buy

08-Apr-2009 -  US company CardioNet, which specialises in mobile cardiac monitoring devices, has made a foray into the contract research sector with a $14m offer to acquire cardiovascular research firm Biotel.

Pfizer awarded for human rights in research

07-Apr-2009 -  Pfizer has become the first drugmaker to win accreditation for protecting the human rights of subjects enrolled into early-stage clinical trials under a scheme operated by the Association for the...

Systems Biology Worldwide buys 4Pharma

25-Mar-2009 -  Contract drug development group Systems Biology Worldwide (SBW) says the acquisition of Finnish data management specialist 4Pharma will facilitate its entry into the clinical trials sector.

Richmond launches new data management offering

11-Mar-2009 -  UK CRO Richmond Pharmacology has unveiled a new data management offering for the drug industry that it claims will help trial sponsors cut costs, save time and help guarantee data...

etrials CEO says ‘08 was ‘challenging’

10-Mar-2009 -  eClinical company etrials saw losses increase in the fourth quarter of 2008, but pointed to a healthy increase in orders as evidence of the underlying strength of the business. 

"Fundamentals for contract research remain strong," says F&S' Barath Shankar

05-Mar-2009 - With M&A activity dominating Big Pharma's agenda at the moment, the contract research market is having to evolve and adapt to the turbulent environmnet. Outsourcing-pharma asked Frost & Sullivan analyst...

Struggling PharmaNet launches new flexible staffing service

05-Mar-2009 -  US CRO PharmaNet hopes its new trial staffing service will provide an additional revenue stream and help stave-off plummeting 2008 incomes and compensate for a series of painful contract cancellations.

Slowdown affecting rebranded eResearch Technology

04-Mar-2009 -  Cardiology and eClinical specialist eResearch Technology missed analysts estimates of sales and earnings in the fourth quarter of 2008, but still posted a near-14 per cent increase in operating profit. ...

Key Industry Events


Access all events listing

Our events, Shows & Conferences...